Latest Safety News

Page 42 of 146
Neurotech International has secured a key FDA designation for its lead drug NTI164, advancing its potential to treat Rett syndrome with regulatory and financial benefits.
Ada Torres
Ada Torres
8 Oct 2025
Immuron Limited has taken a significant step forward by submitting an Investigational New Drug application to the FDA for IMM-529, targeting Clostridioides difficile infection. The company aims to start Phase 2 trials in early 2026, addressing a critical unmet need in infectious disease treatment.
Ada Torres
Ada Torres
8 Oct 2025
Altech Batteries, in partnership with AMPower, has launched a next-generation 384 V / 15 kWh sodium nickel chloride UPS battery designed specifically for Europe's pipeline infrastructure, promising enhanced safety and reliability in explosive environments.
Victor Sage
Victor Sage
8 Oct 2025
Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent, progressing toward a Phase 2 clinical trial with strong collaborations and a recent AU$3.5 million capital raise.
Ada Torres
Ada Torres
7 Oct 2025
Acusensus Limited has landed its first major automated enforcement contract in the US with Connecticut, marking a significant milestone in its American growth strategy. The five-year deal, valued at US$22.6 million, will see the deployment of AI-enabled speed enforcement technology across work zones.
Sophie Babbage
Sophie Babbage
7 Oct 2025
The U.S. FDA has lifted the clinical hold on Neurizon Therapeutics’ lead drug candidate NUZ-001, enabling its entry into a major ALS platform trial set for Q4 2025. This regulatory milestone accelerates the company’s clinical development and opens doors for broader neurodegenerative applications.
Ada Torres
Ada Torres
6 Oct 2025
Electro Optic Systems has landed a significant A$108 million contract to supply remote weapon systems for the Australian Defence Force’s LAND 400-3 project, integrating its technology with Hanwha’s Redback Infantry Fighting Vehicles.
Victor Sage
Victor Sage
6 Oct 2025
Locksley Resources has gained critical regulatory approval and secured contractors to advance its Mojave Project, accelerating exploration of antimony and rare earth elements in California.
Maxwell Dee
Maxwell Dee
3 Oct 2025
Kelsian Group has postponed the start of its new Kangaroo Island ferry service to June 2026, citing vessel delivery delays and aiming to avoid peak season disruptions. The new ferries will significantly increase capacity and offer fare discounts to residents during the transition.
Victor Sage
Victor Sage
3 Oct 2025
Altech has detailed its Sodium Nickel Chloride (SNC) battery technology designed specifically for hazardous explosive environments, highlighting superior safety, longevity, and minimal maintenance compared to traditional battery chemistries.
Victor Sage
Victor Sage
3 Oct 2025
Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.
Ada Torres
Ada Torres
2 Oct 2025
QMines Limited has announced a fully underwritten $1.5 million Share Purchase Plan for existing shareholders, complementing a recent $7.5 million placement to fund exploration at its Mt Mackenzie gold and silver project.
Maxwell Dee
Maxwell Dee
2 Oct 2025